- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02463695
Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs)
Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs): A Comparative Study of Normal Ears Versus Those With Vestibular Deficits
The pathophysiology of vertigo is complex and usually requires specialist involvement. During the diagnostic process, patients commonly undergo tests which assess the integrity of the gaze and posture stabilisation mechanisms involving the inner ear (vestibular system), the visual systems and the subconscious neural pathways that interconnect them. Whilst these tests are useful they fail to provide information concerning the neural connections to the cortex and therefore neglect the perceptual aspects of disequilibrium.
At present the possibility of routine examination of these higher projections remains elusive as no practical alternatives to the expensive functional magnetic resonance imaging systems exist. However, recently a novel method of recording cortical vestibular evoked potentials (CVEPs) has been described.
CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded. The recent breakthrough is in the realisation that these responses also contain information from the balance organs and therefore are a direct measure of cortical processing of the vestibular inputs.
Current evidence shows that CVEPs are present in the normal population and absent in patients with no vestibular function. The primary aim for this study is to extend the patient cohort to include those who have a vestibular injury but retain residual function. Patients going through standard testing will have also have CVEPs on both ears providing seminal information into the effect of injury to the peripheral vestibular system on the cortical pathways. Furthermore, by following the cohort through their complete management pathway it will be possible to ascertain if the CVEP can be used to predict rehabilitation outcome success.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Ears with a vestibular deficit:
Patients referred to the tertiary ear nose and throat clinics as well otoneurological clinics at the Royal Hallamshire will be eligible for enrolment. The investigators aim to record data from 36 ears with vestibular dysfunction.
A) Patients will receive a consultation with an ENT Consultant or Registrar as per standard practice.
B) If the patient is deemed by the doctor to have an otoneurological cause for their symptoms then further audiovestibular testing and imaging will be arranged as per standard practice. The patients will then be made aware of this study and if interested will be given the opportunity to discuss it further with the chief investigator (CI) or the principal investigator (PI).
C) If agreeable the patients will be given information packs by the PI/CI and taken through the study.
D) The patients will leave the consultation with the information pack and be asked to consider participation in the study. They will have no obligation to take part and they can contact the any member of the research team to ask for further information or to have any questions answered.
E) Upon their return for audiovestibular testing the patients will inform the CI/PI if they wish to participate in the study and if so will have an additional test at the end of test sequence. This will add approximately 30 minutes to their appointment time.
F) Patients who are suitable for rehabilitation (as per standard care pathway) will go ahead and have the course of treatment at subsequent visit(s). The outcomes following the treatment will be logged and correlated with the CVEP to check for any correlation that may or may not be present.
Otologically normal ears:
Normative data will be collected from 36 normal ears from subjects that have no history of audiovestibular symptoms and are not being investigated for any balance disorders. Healthy controls will be recruited via poster advertisements and potential participants asked to contact the research team if they are considering taking part.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jemima Clarke
- Phone Number: +44114 226 5938
- Email: Jemima.calrke@sth.nhs.uk
Study Locations
-
-
South Yorkshire
-
Sheffield, South Yorkshire, United Kingdom, S10 2JF
- Recruiting
- Sheffield teaching Hospitals NHS Trust
-
Contact:
- Jemima Clarke
- Phone Number: +441142265938
- Email: jemima.clarke@sth.nhs.uk
-
Principal Investigator:
- Jaswinder S Sandhu, Dr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Vestibular deficit Group:
- Over 18 years of age
- Can provide informed consent
- Deemed to have an otoneurological cause for their symptoms (true vertigo, room spinning even when head is still)
- No middle ear pathology
NORMATIVE GROUP:
- Over 18 years of age
- Can provide informed consent
- No previous otoneurological history
Exclusion Criteria:
VESTIBULAR DEFICIT GROUP PATIENTS
- Participants under the age of 18
- Participants unable to provide informed consent
- Patients not deemed to have an otoneurological cause for their symptoms
- Patients with middle ear pathology
NORMATIVE GROUP:
- Previous history of problems with hearing and or balance
- Participants under the age of 18
- Participants unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: vestibular deficit
|
CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded (known as Cortical Auditory Evoked Potentials CAEPs)
Other Names:
|
ACTIVE_COMPARATOR: otologically normal controll
Normative data will be collected from 36 normal ears from subjects that have no history of audiovestibular symptoms and are not being investigated for any balance disorders.
The cortical vestibular evoked potentials will be recorded from both ears
|
CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded (known as Cortical Auditory Evoked Potentials CAEPs)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The degree of change of cortical vestibular evoked potential measured by amplitude (in microvolts)
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The time interval between the stimulation and response (latency) of cortical vestibular evoked potential
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jaswinder S Sandhu, Dr, Sheffield Teaching Hospitals NHS Foundation Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STH18541
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vestibular Neuronitis
-
Turku University HospitalNot yet recruitingvHIT- and VOG-model for Bilateral Vestibular Neuronitis
-
University of ManitobaCompletedVestibular Neuronitis | Peripheral Vestibular Disorders | Vestibular Syndromes &/or Disorders (Labyrinthine)Canada
-
Lund UniversityTerminatedVestibular Diseases | Vestibular NeuronitisSweden
-
University Hospital, Strasbourg, FranceRecruitingVestibular NeuritisFrance
-
Aristotle University Of ThessalonikiUnknownVestibular NeuritisGreece
-
Aalborg University HospitalCompleted
-
Otolith LabsDizzy and Vertigo Institute of Los AngelesCompletedLabyrinthitis | Vertigo | Dizziness | Vestibular Migraine | Vestibular NeuritisUnited States
-
University Hospital, Strasbourg, FranceCompleted
-
Carmel Medical CenterUniversity Health Network, Toronto; Rambam Health Care Campus; Hillel Yaffe Medical... and other collaboratorsCompleted
-
Asan Medical CenterCompleted
Clinical Trials on cortical vestibular evoked potentials (CVEPs)
-
Augusta UniversityUnknownConstipation | Healthy VolunteersUnited States
-
Assistance Publique - Hôpitaux de ParisActive, not recruiting
-
Chonbuk National UniversityUnknownVestibular Function Disorder
-
University Hospital, ToulouseNot yet recruitingSuperior Semicircular Canal DehiscenceFrance
-
Imperial College Healthcare NHS TrustCompletedPrimary Ciliary DyskinesiaUnited Kingdom
-
Sahlgrenska University Hospital, SwedenGöteborg UniversityRecruitingCardiopulmonary Arrest With Successful Resuscitation | Cardiac Arrest | ResuscitationSweden
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; Jessa Hospital; Queen Fabiola Children's... and other collaboratorsCompletedVestibular Disorder | Hearing Impaired ChildrenBelgium
-
Jessa HospitalRecruitingHearing Loss, Sensorineural | DFNA9 | Radiology | Bilateral Vestibular DeficiencyBelgium
-
Universitaire Ziekenhuizen KU LeuvenFund for Scientific Research, Flanders, BelgiumCompleted
-
University of ManitobaNot yet recruitingMEP Onset Latency